FDA weighs esketamine for depression

Share:

Listens: 0

Daily Medical News

Miscellaneous


Contact us: podcasts@mdedge.com FDA panels back intranasal esketamine for refractory depression. http://bit.ly/2TOKrfp ONC aims to help doctors, patients with information sharing in proposed rule. http://bit.ly/2X3SVkP Survey: Health care costs unlikely to improve in 2019. http://bit.ly/2SwSIYJ Vaccination and antiviral treatment don't lower stroke risk after shingles. http://bit.ly/2tjYQVa